Evidence map›Paper›PMID 38289384›Full record

ArticleApplied microbiology and biotechnology2024

Identification of a novel thermostable transaminase and its application in L-phosphinothricin biosynthesis.

Han-Lin Liu, Pu-Hong Yi, Jia-Min Wu, Feng Cheng, Zhi-Qiang Liu, Li-Qun Jin, Ya-Ping Xue, Yu-Guo Zheng

Open access · goldAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Han-Lin LiuJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Pu-Hong YiJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Jia-Min WuJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Feng ChengJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Zhi-Qiang LiuJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Li-Qun JinJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China. jlq@zjut.edu.cn.ORCID http://orcid.org/0000-0002-6936-609X
Ya-Ping XueJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Yu-Guo ZhengJoint Engineering Research Center for Biomanufacturing of Chiral Chemicals, The National and Local, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
Zhejiang University of Technology · CNMinistry of Education · TH

Funding

National Key R&D Program of China 2020YFA0908400Zhejiang Provincial Science and Technology Innovation Leading Talent program 2022R52041
6 · The paper itself

Abstract

Transaminase (TA) is a crucial biocatalyst for enantioselective production of the herbicide L-phosphinothricin (L-PPT). The use of enzymatic cascades has been shown to effectively overcome the unfavorable thermodynamic equilibrium of TA-catalyzed transamination reaction, also increasing demand for TA stability. In this work, a novel thermostable transaminase (PtTA) from Pseudomonas thermotolerans was mined and characterized. The PtTA showed a high specific activity (28.63 U/mg) towards 2-oxo-4-[(hydroxy)(methyl)phosphinoyl]butyric acid (PPO), with excellent thermostability and substrate tolerance. Two cascade systems driven by PtTA were developed for L-PPT biosynthesis, including asymmetric synthesis of L-PPT from PPO and deracemization of D, L-PPT. For the asymmetric synthesis of L-PPT from PPO, a three-enzyme cascade was constructed as a recombinant Escherichia coli (E. coli G), by co-expressing PtTA, glutamate dehydrogenase (GluDH) and D-glucose dehydrogenase (GDH). Complete conversion of 400 mM PPO was achieved using only 40 mM amino donor L-glutamate. Furthermore, by coupling D-amino acid aminotransferase (Ym DAAT) from Bacillus sp. YM-1 and PtTA, a two-transaminase cascade was developed for the one-pot deracemization of D, L-PPT. Under the highest reported substrate concentration (800 mM D, L-PPT), a 90.43% L-PPT yield was realized. The superior catalytic performance of the PtTA-driven cascade demonstrated that the thermodynamic limitation was overcome, highlighting its application prospect for L-PPT biosynthesis. KEY POINTS: • A novel thermostable transaminase was mined for L-phosphinothricin biosynthesis. • The asymmetric synthesis of L-phosphinothricin was achieved via a three-enzyme cascade. • Development of a two-transaminase cascade for D, L-phosphinothricin deracemization.

Indexed as

AminobutyratesEscherichia coliTransaminasesButyric AcidGlucose 1-DehydrogenaseGlutamic AcidAminobutyratesButyric AcidGlucose 1-DehydrogenaseGlutamic AcidphosphinothricinTransaminasesAsymmetric synthesisDeracemizationEnzyme cascadeL-phosphinothricinThermostable transaminase

Identifiers

PMID38289384
PMCPMC10827958
OpenAlexW4391360119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.